Dr. Rakesh Suri, President and Chief Medical Officer at Fountain Life, a preventative health and longevity company discusses Fountain Life’s unique data-driven approach that enables finding illnesses, including cancer, cardiac, metabolic, and neurodegenerative disease, early before they can cause harm. The company has three open U.S. sites in Naples, FL, Dallas, TX, and White Plains, NY. Dr. Suri talks about how they are planning to transform global healthcare from reactive to proactive not only across the United States but globally.
Before joining Fountain Life, Dr. Suri was President of International Operations and a practicing cardiothoracic surgeon at Cleveland Clinic in Ohio. In that role, he worked collaboratively to expand “One Cleveland Clinic” in the U.S. and abroad, including Global Business Development and Facilitated Access. He also served as CEO and President of Cleveland Clinic Abu Dhabi from 2017-2021. Prior to that, he was a consultant in the Division of Cardiovascular Surgery, Professor of Surgery and Chair of the Enterprise Robotic Practice at Mayo Clinic. He has completed more than 7,000 surgical procedures in his career, is Past-President of The Heart Valve Society, a Diplomate of the American Board of Thoracic Surgery and an Editorial Board Member of the Journal of Thoracic and Cardiovascular Surgery. His significant research pursuits include contributions to more than 340 peer-reviewed journal articles and book chapters, more than 15 patents and several FDA multicenter trials.